查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1320036

視網膜病變治療藥物市場：按類型、劑型、分銷管道分類 - 全球預測 2023-2030

Retinal Disorder Treatment Market by Type, Dosage Form, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球視網膜病變治療藥物市場將達86.2389億美元，年複合成長率為8.92%，大幅成長，2030年將達到157.938億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球視網膜病變藥物市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球視網膜疾病治療藥物市場規模及預測為何？

2.在預測期內，COVID-19 對全球視網膜病變治療藥物市場的阻礙因素與影響為何？

3.在預測期內，全球視網膜病變治療藥物市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球視網膜疾病治療藥物市場的競爭策略是什麼？

5.全球治療視網膜疾病藥物市場的技術趨勢和法律規範是什麼？

6.全球視網膜病變治療藥物市場主要廠商的市佔率為何？

7. 哪些型態和策略性舉措被認為適合進入視網膜病變藥物全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 擴大對眼科疾病研究的法規資金
      • 全球視網膜疾病盛行率增加
      • 老年人口增加和黃斑部病變
    • 抑制因素
      • 研究和開發活動花費大量資金
    • 機會
      • 技術創新和治療進展
      • 擴大策略合作並將新產品商業化
    • 任務
      • 可能出現眼部併發症
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 視網膜病變治療藥物市場：依類型

  • 糖尿病性視網膜病變
  • 黃斑部病變
    • 乾性黃斑部病變
    • 濕性黃斑部病變

第7章 依劑型分類的視網膜病變治療藥物市場

  • 膠囊和錠劑
  • 眼藥水
  • 眼液
  • 凝膠
  • 軟膏

第8章 視網膜病變治療藥物市場：依分銷管道

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章 北美及南美視網膜病變治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太視網膜病變治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲視網膜病變治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-CA17E905E6FD

The Global Retinal Disorder Treatment Market is forecasted to grow significantly, with a projected USD 8,623.89 million in 2023 at a CAGR of 8.92% and expected to reach a staggering USD 15,709.38 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Retinal Disorder Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Retinal Disorder Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Diabetic Retinopathy and Macular Degeneration. The Macular Degeneration is further studied across Dry Macular Degeneration and Wet Macular Degeneration. The Diabetic Retinopathy is projected to witness significant market share during forecast period.

Based on Dosage Form, market is studied across Capsules & Tablets, Eye Drops, Eye Solutions, Gels, and Ointments. The Eye Drops is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Hospital Pharmacy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Retinal Disorder Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Retinal Disorder Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Retinal Disorder Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Retinal Disorder Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Retinal Disorder Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Retinal Disorder Treatment Market?

6. What is the market share of the leading vendors in the Global Retinal Disorder Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Retinal Disorder Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Retinal Disorder Treatment Market, by Type, 2022 vs 2030
  • 4.3. Retinal Disorder Treatment Market, by Dosage Form, 2022 vs 2030
  • 4.4. Retinal Disorder Treatment Market, by Distribution Channel, 2022 vs 2030
  • 4.5. Retinal Disorder Treatment Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing funding by regulatory bodies for research on ocular disorders
      • 5.1.1.2. Increasing prevalence of retinal disorders globally
      • 5.1.1.3. Rising elderly population coupled with macular degeneration
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in research and development activities
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations and advancements in treatments
      • 5.1.3.2. Growing strategic collaborations and commercialization of novel products
    • 5.1.4. Challenges
      • 5.1.4.1. Probable complications in the eye
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Retinal Disorder Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Diabetic Retinopathy
  • 6.3. Macular Degeneration
    • 6.3.1. Dry Macular Degeneration
    • 6.3.2. Wet Macular Degeneration

7. Retinal Disorder Treatment Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Capsules & Tablets
  • 7.3. Eye Drops
  • 7.4. Eye Solutions
  • 7.5. Gels
  • 7.6. Ointments

8. Retinal Disorder Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Americas Retinal Disorder Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Retinal Disorder Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Retinal Disorder Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. RETINAL DISORDER TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. RETINAL DISORDER TREATMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. RETINAL DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2022 VS 2030 (%)
  • FIGURE 6. RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 7. RETINAL DISORDER TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. RETINAL DISORDER TREATMENT MARKET DYNAMICS
  • FIGURE 9. RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. RETINAL DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. RETINAL DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. RETINAL DISORDER TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. RETINAL DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 7. RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. RETINAL DISORDER TREATMENT MARKET SIZE, BY DRY MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. RETINAL DISORDER TREATMENT MARKET SIZE, BY WET MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 11. RETINAL DISORDER TREATMENT MARKET SIZE, BY CAPSULES & TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. RETINAL DISORDER TREATMENT MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. RETINAL DISORDER TREATMENT MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. RETINAL DISORDER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. RETINAL DISORDER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. RETINAL DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 189. RETINAL DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 190. RETINAL DISORDER TREATMENT MARKET LICENSE & PRICING